NEW YORK (GenomeWeb News) – Covance and PathoQuest said today that the companies will collaborate to develop a next-generation sequencing-based assay for biosafety testing for the pharmaceutical industry.

PathoQuest is a startup based in Paris and is developing next-gen sequencing-based infectious disease diagnostics. In the collaboration with Covance, the companies will develop assays to screen pharmaceutical products for viral contaminants.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.